Rein Therapeutics (RNTX) Research & Development (2016 - 2026)
Rein Therapeutics (RNTX) recorded Research & Development of $3.64 million in Q2 2026, down 15.2% from $4.29 million a year earlier but up 18.4% from the prior quarter.
Powered by 
Analysis
Rein Therapeutics (RNTX) Research & Development (2016 - 2026) Analysis & Trends
On a TTM basis, Rein Therapeutics' Research & Development came in at $10.39 million as of Jun 30, 2026, down 27.8% year-over-year; for FY2025, it came in at $11.03 million, down 22.6% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $14.25 million in FY2024 (+257.0%), $3.99 million in FY2023 (-77.8%), $17.97 million in FY2022 (+5.6%) and $17.01 million in FY2021 (+52.3%).
- Quarterly Research & Development has ranged from $22,000 in Q3 2023 to $5.89 million in Q1 2022 over the past five years.
- On a year-over-year basis, Research & Development rose in three of the last seven quarters, with an average decline of 5.4%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 136.9% in Q4 2021, against a decline of 99.5% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.07 million (Q1 2026), $2 million (Q4 2025) and $1.68 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Rein Therapeutics | 48.30 Mn | 48.30 Mn | - | 3.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.64 Mn |
| Mar 31, 2026 | 3.07 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 4.29 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 3.32 Mn |
| Sep 30, 2024 | 3.72 Mn |
| Jun 30, 2024 | 3.74 Mn |
| Mar 31, 2024 | 3.46 Mn |
| Dec 31, 2023 | 1.97 Mn |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 187,000.00 |
| Mar 31, 2023 | 1.81 Mn |
| Dec 31, 2022 | 2.40 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Jun 30, 2022 | 5.43 Mn |
| Mar 31, 2022 | 5.89 Mn |
| Dec 31, 2021 | 4.56 Mn |
| Sep 30, 2021 | 4.28 Mn |
API Access
Rein Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();